Cas:1017789-45-5 N-(2,3-Dimethyl-4-nitrophenyl)-2,2-dimethylpropanamide manufacturer & supplier

We serve Chemical Name:N-(2,3-Dimethyl-4-nitrophenyl)-2,2-dimethylpropanamide CAS:1017789-45-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-(2,3-Dimethyl-4-nitrophenyl)-2,2-dimethylpropanamide

Chemical Name:N-(2,3-Dimethyl-4-nitrophenyl)-2,2-dimethylpropanamide
CAS.NO:1017789-45-5
Synonyms:N-(2,3-Dimethyl-4-nitrophenyl)-2,2-dimethylpropanamide
Molecular Formula:C13H18N2O3
Molecular Weight:250.29400
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:74.92000
Exact Mass:250.13200
LogP:3.79240

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-(2,3-Dimethyl-4-nitrophenyl)-2,2-dimethylpropanamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(2,3-Dimethyl-4-nitrophenyl)-2,2-dimethylpropanamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(2,3-Dimethyl-4-nitrophenyl)-2,2-dimethylpropanamide Use and application,N-(2,3-Dimethyl-4-nitrophenyl)-2,2-dimethylpropanamide technical grade,usp/ep/jp grade.


Related News: The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion. N-(2,3-Dimethyl-4-nitrophenyl)-2,2-dimethylpropanamide manufacturer As a result, the Company��s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy. N-(2,3-Dimethyl-4-nitrophenyl)-2,2-dimethylpropanamide supplier As a result, the Company��s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy. N-(2,3-Dimethyl-4-nitrophenyl)-2,2-dimethylpropanamide vendor The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion. N-(2,3-Dimethyl-4-nitrophenyl)-2,2-dimethylpropanamide factory The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant��s collection.